Sean M. Hayes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sean M. Hayes has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Carolyn R. Cho
Quantitative Pharmacology and Pharmacometrics, Merck & Co., Inc., Kenilworth, USA
1 shared publication- Douglas Chung
Certara Inc, Radnor, USA
1 shared publication - Jeffrey R. Sachs
Merck & Co., Inc., Rahway, USA
1 shared publication Kurt E. Anderson
University of California Riverside
1 shared publication- Kurt E. Anderson
University of California Riverside
1 shared publication - Maria E. Trujillo
Merck & Co., Inc., Rahway, NJ 07065, USA
1 shared publication
Latest Publications
- Open Access
- 26 November 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (12) , 1522
In Silico Hypothesis Testing in Drug Discovery: Using Quantitative Systems Pharmacology Modeling to Evaluate the Therapeutic Value of Proinsulin Conversion to Insulin Therapy for Type 2 Diabetes Mellitus
Background/Objectives: Proinsulin, the precursor to insulin, has limited activity on the insulin receptor. Proinsulin levels increase with increasing insulin resistance in type 2 diabetes due to incomplete processing by the β-cell. To assess whether the development of peptides that could convert circulating proinsulin to insulin in the blood would provide therapeutic value, we used a quantitative systems pharmacology (QSP) model of glucose homeostasis. In silico hypothesis testing such as this is an example of how modeling can inform decisions in drug discovery. Methods: In silico hypothesis testing involved (1) the addition and qualification of proinsulin biology into a preexisting QSP model, (2) the creation and validation of virtual patients (VPs) for subpopulations of type 2 diabetics based on phenotypic traits, and (3) the simulation of clinical trials evaluating the therapeutic value of the conversion of circulating proinsulin to insulin in the VPs created. Results: Proinsulin conversion led to a ~0.2% reduction in HbA1c in VPs at varying stages of diabetes, a decrease that does not hold meaningful therapeutic value. The lack of significant impact on HbA1c was likely a result of the surprisingly small effect on plasma insulin levels from proinsulin, which has a significantly slower secretion and clearance rate. Although patients with higher proinsulin/insulin ratios showed the largest reductions, clinically significant ≥ 0.5% reduction in HbA1c required ratios of proinsulin/insulin above the reported physiological range. Conclusions: This effort demonstrates how in silico hypothesis testing using QSP modeling can provide insights on the probability of success of novel interventions with minimal time and resources. These efficiencies are a means of overcoming the pressures on the pharmaceutical industry to do more with less in providing therapies that improve the lives of patients.
- 26 November 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (12) , 1522
Open AccessIn Silico Hypothesis Testing in Drug Discovery: Using Quantitative Systems Pharmacology Modeling to Evaluate the Therapeutic Value of Proinsulin Conversion to Insulin Therapy for Type 2 Diabetes Mellitus
Background/Objectives: Proinsulin, the precursor to insulin, has limited activity on the insulin receptor. Proinsulin levels increase with increasing insulin resistance in type 2 diabetes due to incomplete processing by the β-cell. To assess whether the development of peptides that could convert circulating proinsulin to insulin in the blood would provide therapeutic value, we used a quantitative systems pharmacology (QSP) model of glucose homeostasis. In silico hypothesis testing such as this is an example of how modeling can inform decisions in drug discovery. Methods: In silico hypothesis testing involved (1) the addition and qualification of proinsulin biology into a preexisting QSP model, (2) the creation and validation of virtual patients (VPs) for subpopulations of type 2 diabetics based on phenotypic traits, and (3) the simulation of clinical trials evaluating the therapeutic value of the conversion of circulating proinsulin to insulin in the VPs created. Results: Proinsulin conversion led to a ~0.2% reduction in HbA1c in VPs at varying stages of diabetes, a decrease that does not hold meaningful therapeutic value. The lack of significant impact on HbA1c was likely a result of the surprisingly small effect on plasma insulin levels from proinsulin, which has a significantly slower secretion and clearance rate. Although patients with higher proinsulin/insulin ratios showed the largest reductions, clinically significant ≥ 0.5% reduction in HbA1c required ratios of proinsulin/insulin above the reported physiological range. Conclusions: This effort demonstrates how in silico hypothesis testing using QSP modeling can provide insights on the probability of success of novel interventions with minimal time and resources. These efficiencies are a means of overcoming the pressures on the pharmaceutical industry to do more with less in providing therapies that improve the lives of patients.
- Open Access
- 17 November 2021
- Published by Springer Nature in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 49 (1) , 81-99
From complex data to biological insight: ‘DEKER’ feature selection and network inference
Network inference is a valuable approach for gaining mechanistic insight from high-dimensional biological data. Existing methods for network inference focus on ranking all possible relations (edges) among all measured quantities such as genes, proteins, metabolites (features) observed, which yields a dense network that is challenging to interpret. Identifying a sparse, interpretable network using these methods thus requires an error-prone thresholding step which compromises their performance. In this article we propose a new method, DEKER-NET, that addresses this limitation by directly identifying a sparse, interpretable network without thresholding, improving real-world performance. DEKER-NET uses a novel machine learning method for feature selection in an iterative framework for network inference. DEKER-NET is extremely flexible, handling linear and nonlinear relations while making no assumptions about the underlying distribution of data, and is suitable for categorical or continuous variables. We test our method on the Dialogue for Reverse Engineering Assessments and Methods (DREAM) challenge data, demonstrating that it can directly identify sparse, interpretable networks without thresholding while maintaining performance comparable to the hypothetical best-case thresholded network of other methods.
- 17 November 2021
- Published by Springer Nature in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 49 (1) , 81-99
Open AccessFrom complex data to biological insight: ‘DEKER’ feature selection and network inference
Network inference is a valuable approach for gaining mechanistic insight from high-dimensional biological data. Existing methods for network inference focus on ranking all possible relations (edges) among all measured quantities such as genes, proteins, metabolites (features) observed, which yields a dense network that is challenging to interpret. Identifying a sparse, interpretable network using these methods thus requires an error-prone thresholding step which compromises their performance. In this article we propose a new method, DEKER-NET, that addresses this limitation by directly identifying a sparse, interpretable network without thresholding, improving real-world performance. DEKER-NET uses a novel machine learning method for feature selection in an iterative framework for network inference. DEKER-NET is extremely flexible, handling linear and nonlinear relations while making no assumptions about the underlying distribution of data, and is suitable for categorical or continuous variables. We test our method on the Dialogue for Reverse Engineering Assessments and Methods (DREAM) challenge data, demonstrating that it can directly identify sparse, interpretable networks without thresholding while maintaining performance comparable to the hypothetical best-case thresholded network of other methods.
- Open Access
- 20 December 2019
- Published by Springer Nature in Bulletin of Mathematical Biology
- Vol. 82 (1) , 4
Predicting Pattern Formation in Multilayer Networks
We investigate how the structure of interactions between coupled oscillators influences the formation of asynchronous patterns in a multilayer network by formulating a simple, general multilayer oscillator model. We demonstrate the analysis of this model in three-oscillator systems, illustrating the role of interactions among oscillators in sustaining differences in both the phase and amplitude of oscillations leading to the formation of asynchronous patterns. Finally, we demonstrate the generalizability of our model’s predictions through comparison with a more realistic multilayer model. Overall, our model provides a useful approach for predicting the types of asynchronous patterns that multilayer networks of coupled oscillators which cannot be achieved by the existing methods which focus on characterizing the synchronous state.
- 20 December 2019
- Published by Springer Nature in Bulletin of Mathematical Biology
- Vol. 82 (1) , 4
Open AccessPredicting Pattern Formation in Multilayer Networks
We investigate how the structure of interactions between coupled oscillators influences the formation of asynchronous patterns in a multilayer network by formulating a simple, general multilayer oscillator model. We demonstrate the analysis of this model in three-oscillator systems, illustrating the role of interactions among oscillators in sustaining differences in both the phase and amplitude of oscillations leading to the formation of asynchronous patterns. Finally, we demonstrate the generalizability of our model’s predictions through comparison with a more realistic multilayer model. Overall, our model provides a useful approach for predicting the types of asynchronous patterns that multilayer networks of coupled oscillators which cannot be achieved by the existing methods which focus on characterizing the synchronous state.
- 17 November 2017
- Published by Springer Nature in Theoretical Ecology
- Vol. 11 (2) , 151-159
Beyond connectivity: how the structure of dispersal influences metacommunity dynamics
- 17 November 2017
- Published by Springer Nature in Theoretical Ecology
- Vol. 11 (2) , 151-159
Beyond connectivity: how the structure of dispersal influences metacommunity dynamics